Hub Cleansing to Prevent Hub Infection (HUC-PHIN)

This study is enrolling participants by invitation only.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Rush University Medical Center
ClinicalTrials.gov Identifier:
NCT01563406
First received: February 15, 2012
Last updated: March 26, 2012
Last verified: March 2012

February 15, 2012
March 26, 2012
March 2012
December 2012   (final data collection date for primary outcome measure)
Number of central venous catheter hubs with internal contamination [ Time Frame: 10 months ] [ Designated as safety issue: No ]
This will be a qualitative outcome. It will be reported as "yes" or "no" for central venous catheter hub internal contamination. The number of hubs with internal contamination will be compared for the two comparators (disinfecting agent and duration of cleansing).
Same as current
Complete list of historical versions of study NCT01563406 on ClinicalTrials.gov Archive Site
Number of contaminated central venous catheter tips [ Time Frame: 10 months ] [ Designated as safety issue: No ]
This will be a qualitative measure for central venous catheter tip contamination. The results will be reported as "yes" or "no".
Same as current
Not Provided
Not Provided
 
Hub Cleansing to Prevent Hub Infection
Hub Cleansing to Prevent Hub Infection

Central venous catheter infections are common preventable adverse events among hospital patients. Microbes may enter catheter hubs, also known as needleless connectors, and result in downstream contamination. This study aims to compare alcohol disinfection of catheter hubs to disinfection with chlorhexidine gluconate in alcohol, which has been proven to be a superior disinfectant at the site of central venous catheter insertion. Scrub duration of central venous catheter hubs will also be evaluated.

A prospective randomized blinded crossover clinical trial will be performed in the medical intensive care unit at Rush University Medical Center. The intensive care unit will be divided into two regions (A&B). Hub disinfectants and duration of disinfection will be randomly assigned to these regions. After 1/2 of the study period, the agents will crossover, but the duration of scrubbing will remain the same, analogous to a 2X2 factorial design. Our primary endpoint will be internal contamination of hubs and catheters.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Double Blind (Subject, Caregiver)
Primary Purpose: Prevention
Catheter-related Bloodstream Infection
  • Other: 15 second scrub
    Catheter hubs are normally cleansed prior to accessing the central venous line. All catheter hubs in this arm will be scrubbed for 15 seconds.
  • Other: 5 second scrub
    Catheter hubs are normally cleansed prior to accessing the central venous line. All catheter hubs in this arm will be scrubbed for 5 seconds.
  • Drug: 3.15% chlorhexidine/70% isopropyl alcohol
    3.15% chlorhexidine gluconate in 70% isopropyl alcohol pads will be used to disinfect catheter hubs prior to accessing central venous catheters during half of the study period.
    Other Name: Professional Disposables International, Inc. (PDI) Chlorascrub Swab
  • Drug: 70% isopropyl alcohol
    70% isopropyl alcohol pads will be used to disinfect catheter hubs prior to accessing central venous catheters for the other half of the study period.
    Other Name: Professional Disposable International, Inc. (PDI) Alcohol Prep Pad
  • Experimental: Region A
    One region of the MICU at Rush University Medical Center will be designated region A.
    Interventions:
    • Other: 15 second scrub
    • Drug: 3.15% chlorhexidine/70% isopropyl alcohol
    • Drug: 70% isopropyl alcohol
  • Experimental: Region B
    One region of the MICU at Rush University Medical Center will be designated region B.
    Interventions:
    • Other: 5 second scrub
    • Drug: 3.15% chlorhexidine/70% isopropyl alcohol
    • Drug: 70% isopropyl alcohol
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Enrolling by invitation
800
December 2012
December 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Medical intensive care unit patients with non-tunneled central venous catheters

Exclusion Criteria:

  • Dialysis catheters
  • Antibiotic-impregnated catheters
  • Introducer sheaths
  • Tunneled catheters
Both
16 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01563406
U54CK000161-01W1
No
Rush University Medical Center
Rush University Medical Center
Centers for Disease Control and Prevention
Principal Investigator: Mary K Hayden, MD Rush University Medical Center
Principal Investigator: Robert A Weinstein, MD Cook County Health and Hospital Systems
Rush University Medical Center
March 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP